These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 3939546)

  • 1. Disturbed metabolism of copper and zinc in aspartylglycosaminuria: possible involvement with connective tissue changes.
    Näntö-Salonen K; Halme T; Penttinen R; Langevelde FV; Vis RD; Alfthan G
    J Inherit Metab Dis; 1985; 8(4):212-8. PubMed ID: 3939546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Copper and zinc metabolism in aspartylglycosaminuria and Salla disease.
    van Langevelde F; Vis RD; Näntö-Salonen K; Halme T; Pakarinen P; Hyörä H; Vuorinen K; Näntö V
    Sci Total Environ; 1985 Mar; 42(1-2):171-80. PubMed ID: 4012278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of aspartylglycosaminuria by gas--liquid chromatography.
    Maury CP
    Clin Chem; 1981 Dec; 27(12):2058-60. PubMed ID: 7307258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal dermal proteoglycan in aspartylglycosaminuria: a possible mechanism for ultrastructural changes of collagen fibrils in a glycoprotein storage disorder.
    Näntö-Salonen K; Larjava H; Säämanen AM; Heino J; Penttinen R; Pelliniemi LJ; Tammi M
    Connect Tissue Res; 1987; 16(4):367-76. PubMed ID: 3132350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liquid-chromatographic detection of aspartylglycosaminuria.
    Mononen T; Parviainen M; Penttilä I; Mononen I
    Clin Chem; 1986 Mar; 32(3):501-2. PubMed ID: 3948393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of collagen in aspartylglycosaminuria: urinary excretion of hydroxyproline.
    Näntö-Salonen K; Autio S; Härö E; Kivimäki T; Koskela SL; Näntö V; Penttinen R
    J Inherit Metab Dis; 1984; 7(3):117-21. PubMed ID: 6438393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary glycosaminoglycans in aspartylglycosaminuria: evidence for disturbed proteoglycan metabolism.
    Näntö-Salonen K; Larjava H; Aalto M; Kivimäki T
    Clin Chim Acta; 1985 Mar; 146(2-3):111-8. PubMed ID: 3987044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-Acetylglucosamine-asparagine levels in tissues of patients with aspartylglycosaminuria.
    Maury CP; Palo J
    Clin Chim Acta; 1980 Dec; 108(2):293-9. PubMed ID: 7449147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenatal diagnosis and fetal pathology of aspartylglucosaminuria.
    Aula P; Rapola J; von Koskull H; Ammälä P
    Am J Med Genet; 1984 Oct; 19(2):359-67. PubMed ID: 6507482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspartylglucosamine excretion in heterozygous carriers of aspartylglycosaminuria.
    Mononen TK
    Clin Chim Acta; 1989 Mar; 180(1):99-101. PubMed ID: 2743573
    [No Abstract]   [Full Text] [Related]  

  • 11. Metabolism of collagen in aspartylglycosaminuria: decreased synthesis by cultured fibroblasts.
    Näntö-Salonen K; Penttinen R
    J Inherit Metab Dis; 1982; 5(4):197-203. PubMed ID: 6820441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laboratory detection of aspartylglycosaminuria.
    Mononen I; Kaartinen V; Mononen T
    Scand J Clin Lab Invest Suppl; 1988; 191():7-11. PubMed ID: 3247584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspartylglycosaminuria in an Italian family: clinical and biochemical characteristics.
    Gehler J; Sewell AC; Becker C; Spranger J; Hartmann J
    J Inherit Metab Dis; 1981; 4(4):229-30. PubMed ID: 6796777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the storage material of peripheral lymphocytes in aspartylglycosaminuria.
    Maury P; Palo J
    Clin Sci (Lond); 1980 Feb; 58(2):165-8. PubMed ID: 7357836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated levels of serum dolichol in aspartylglucosaminuria.
    Salaspuro M; Salmela K; Humaloja K; Autio S; Arvio M; Palo J
    Life Sci; 1990; 47(7):627-32. PubMed ID: 2402187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and biochemical delineation of aspartyl-glycosaminuria as observed in two members of an Italian family.
    Gehler J; Sewell AC; Becker C; Hartmann J; Spranger J
    Helv Paediatr Acta; 1981; 36(2):179-89. PubMed ID: 6788730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal collagen fibrils in aspartylglycosaminuria. Altered dermal ultrastructure in a glycoprotein storage disorder.
    Näntö-Salonen K; Pelliniemi LJ; Autio S; Kivimäki T; Rapola J; Penttinen R
    Lab Invest; 1984 Oct; 51(4):464-8. PubMed ID: 6592395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aspartylglycosaminuria in Northern Norway in eight patients: clinical heterogeneity and variations with the diet.
    Borud O; Strömme JH; Lie SO; Torp KH
    J Inherit Metab Dis; 1978; 1(3):95-7. PubMed ID: 116085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspartylglycosaminuria: an inborn error of glycoprotein catabolism.
    Maury CP
    J Inherit Metab Dis; 1982; 5(4):192-6. PubMed ID: 6820440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sleep disturbances in aspartylglucosaminuria (AGU): a questionnaire study.
    Lindblom N; Kivinen S; Heiskala H; Laakso ML; Kaski M
    J Inherit Metab Dis; 2006 Oct; 29(5):637-46. PubMed ID: 16944277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.